HuagongsheHuagongshe Chemistry Print Report · For research reference only
Naratriptan → HCID 86670066, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Naratriptan | HCID 4440 | — |
| Reactant | Potassium Hydroxide | HCID 14797 | — |
| Reactant | 5-Bromoindole | HCID 24905 | — |
| Reactant | 1-Methyl-4-piperidone | HCID 74049 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 86670066 | HCID 86670066 | — |
Reaction Steps
U.S. Pat. No. 4,997,841 discloses naratriptan, its salts and several processes for its preparation. One of the processes comprises reacting 5-bromoindole with 1-methylpiperidin-4-one by means of KOH in methanol at room temperature to give 5-bromo-3-(4-(hydroxy-1-methylpiperidin-4-yl)-1H-indole, which is condensed with N-methylvinylsulfonamide by means of palladium acetate and tri-p-tolyl phosphine in hot DMF to afford (E)-N-methyl-2-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-5-yl]vinylsulfonamide. Finally, this compound is hydrogenated with H2 over Pd/C to obtain naratriptan.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08735589B2 |
| Source dataset | uspto-grants-2014_05 |
| ORD ID | ord-4d8e9d0540194d3384fe35e51c93d3dc |
| Source note | uspto-grants-2014_05 |